https://m2.mtmt.hu/ hun 2026-04-16 15:33 JournalArticle 31926259 VALIDATED true 0 false 2026-04-07T08:05:33.302+0000 2024-12-06T17:57:51.565+0000 2021-03-22T11:35:44.321+0000 true 10000109 Győrffy Balázs /api/author/10000109 Author Győrffy Balázs (Onkológia) true 10000109 2023-10-30T03:22:16.545+0000 2023-10-30T03:22:16.545+0000 2024-12-06T17:57:51.936+0000 true 10039043 Milánkovics Róbert /api/admin/10039043 Admin Milánkovics Róbert (PTE ÁOK admin 4) true 10039043 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Nagy, Á. true true /api/journal/10019966 REVIEWED SCIENTIFIC REPORTS 2045-2322 true false 10019966 false 10019966 true 2045-2322 Journal FOREIGN 11 1 6047 6047 10 2021 Cancer hallmark genes are responsible for the most essential phenotypic characteristics of malignant transformation and progression. In this study, our aim was to estimate the prognostic effect of the established cancer hallmark genes in multiple distinct cancer types. RNA-seq HTSeq counts and survival data from 26 different tumor types were acquired from the TCGA repository. DESeq was used for normalization. Correlations between gene expression and survival were computed using the Cox proportional hazards regression and by plotting Kaplan–Meier survival plots. The false discovery rate was calculated to correct for multiple hypothesis testing. Signatures based on genes involved in genome instability and invasion reached significance in most individual cancer types. Thyroid and glioblastoma were independent of hallmark genes (61 and 54 genes significant, respectively), while renal clear cell cancer and low grade gliomas harbored the most prognostic changes (403 and 419 genes significant, respectively). The eight genes with the highest significance included BRCA1 (genome instability, HR 4.26, p < 1E−16), RUNX1 (sustaining proliferative signaling, HR 2.96, p = 3.1E−10) and SERPINE1 (inducing angiogenesis, HR 3.36, p = 1.5E−12) in low grade glioma, CDK1 (cell death resistance, HR = 5.67, p = 2.1E−10) in kidney papillary carcinoma, E2F1 (tumor suppressor, HR 0.38, p = 2.4E−05) and EREG (enabling replicative immortality, HR 3.23, p = 2.1E−07) in cervical cancer, FBP1 (deregulation of cellular energetics, HR 0.45, p = 2.8E−07) in kidney renal clear cell carcinoma and MYC (invasion and metastasis, HR 1.81, p = 5.8E−05) in bladder cancer. We observed unexpected heterogeneity and tissue specificity when correlating cancer hallmark genes and survival. These results will help to prioritize future targeted therapy development in different types of solid tumors. © 2021, The Author(s). Funding 2008854 /api/funding/2008854 Magyar-koreai kutatás-fejlesztési együttműködési pályázat(2018-2.1.17-TÉT-KR-00001) Támogató: NKFIH false true Funding 2008855 /api/funding/2008855 (2018-1.3.1-VKE-2018-00032) false true Funding 2008856 /api/funding/2008856 Thematic Excellence Program (Semmelweis University)(2020-4.1.1.-TKP2020) Támogató: Innovációs és Technológiai Minisztérium false true Funding 2008857 /api/funding/2008857 (ÚNKP-19-3-IV-SE-5) Támogató: Innovációs és Technológiai Minisztérium false true 2021 true true true false true false GOLD 2026-04-07 true https://doi.org/10.1038/s41598-021-84787-5 795 0 795 784 13 793 781 769 729 795 795 784 784 784 11 0 795 784 795 784 0 3 3 Folyóiratcikk Journal Article 24 787 Könyvrészlet Chapter in Book 25 7 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 1 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2021 0 141 138 141 138 2022 0 248 245 248 245 2023 0 167 167 167 167 2024 0 136 133 136 133 2025 0 94 92 94 92 2026 0 9 9 9 9 D1 A nemzetközi false 10000109,10024232 false false false 2021-03-25T12:07:47.163+0000 Bioinformatika Tanszék (SE / AOK / I); Onkológiai Biomarker Kutatócsoport (Lendület) (HRN TTK / MÉI) 3 28 2 3 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 95758778 /api/authorship/95758778 Nagy, Á. [Nagy, Ádám (biológia), szerző] Bioinformatika Tanszék (SE / AOK / I) 1 0.33333334 true false false Author 10047679 /api/author/10047679 Nagy Ádám (biológia) Nagy Ádám true 10047679 true Nagy Á. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 95758779 /api/authorship/95758779 Munkácsy, G. [Munkácsy, Gyöngyi (onkológia), szerző] Bioinformatika Tanszék (SE / AOK / I) 2 0.33333334 false false false Author 10024232 /api/author/10024232 Munkácsy Gyöngyi (onkológia) Munkácsy Gyöngyi true 10024232 true Munkácsy G. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 95758780 /api/authorship/95758780 Győrffy, B. ✉ [Győrffy, Balázs (Onkológia), szerző] Onkológiai Biomarker Kutatócsoport (Lendület) (HRN TTK / MÉI); Bioinformatika Tanszék (SE / AOK / I) 3 0.333 false true true Author 10000109 /api/author/10000109 Győrffy Balázs (Onkológia) Győrffy Balázs true 10000109 true Győrffy B. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 18553116 /api/publicationidentifier/18553116 DOI: 10.1038/s41598-021-84787-5 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.1038/s41598-021-84787-5 https://doi.org/10.1038/s41598-021-84787-5 false true PublicationIdentifier 18570256 /api/publicationidentifier/18570256 WoS: 000630516600007 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000630516600007 https://www.webofscience.com/wos/woscc/full-record/000630516600007 false true PublicationIdentifier 18553115 /api/publicationidentifier/18553115 Scopus: 85102520763 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85102520763 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85102520763 false true PublicationIdentifier 18570257 /api/publicationidentifier/18570257 PubMed: 33723286 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 33723286 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=33723286&dopt=Abstract false true MtaRating 519359 /api/mtarating/519359 IX. Szociológiai Tudományos Bizottság:A nemzetközi SCIENTIFIC REPORTS 2045-2322 RatingType 10007 /api/ratingtype/10007 IX. Szociológiai Tudományos Bizottság SZTB Institute 14102 /api/institute/14102 Szociológiai Tudományos Bizottság IXGJO SZTB [1901-] 0 false true false Szociológiai Tudományos Bizottság Committee on Sociology true 14102 true true true A nemzetközi true 19359 true MtaRating 11551161 /api/mtarating/11551161 IX. Regionális Tudományok Bizottsága:B nemzetközi SCIENTIFIC REPORTS 2045-2322 RatingType 10010 /api/ratingtype/10010 IX. Regionális Tudományok Bizottsága RegTB Institute 14100 /api/institute/14100 Regionális Tudományok Bizottsága IXGJO RTB [1901-] 0 false true false Regionális Tudományok Bizottsága Committee on Regional Studies true 14100 true true true B nemzetközi false true SjrRating 11184995 /api/sjrrating/11184995 sjr:D1 (2021) Scopus - Multidisciplinary SCIENTIFIC REPORTS 2045-2322 11 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1000 /api/classificationexternal/1000 Scopus - Multidisciplinary true 1000 true D1 DIRECT true true Reference 19181522 /api/reference/19181522 1. Subramanian, A., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles (2005) Proc. Natl. Acad. Sci. U.S.A., 102, pp. 15545-15550 1 false true Reference 19181521 /api/reference/19181521 2. Sturn, A., Quackenbush, J., Trajanoski, Z., Genesis: Cluster analysis of microarray data (2002) Bioinformatics, 18, pp. 207-208. , COI: 1:CAS:528:DC%2BD38Xhs1eksro%3D 2 false true Reference 19181520 /api/reference/19181520 3. Anders, S., Huber, W., Differential expression analysis for sequence count data (2010) Genome Biol., 11, p. R106 3 false true Reference 19181519 /api/reference/19181519 4. Vallat, L., The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays (2003) Blood, 101, pp. 4598-4606 4 false true Reference 19181518 /api/reference/19181518 5. Hofmann, W.K., Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray (2001) Blood, 98, pp. 787-794. , COI: 1:CAS:528:DC%2BD3MXlsFKru7w%3D 5 false true Reference 19181517 /api/reference/19181517 6. Jourdan, M., Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells (2009) Br. J. Haematol., 145, pp. 45-58 6 false true Reference 19181516 /api/reference/19181516 7. Holleman, A., The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia (2006) Blood, 107, pp. 769-776 7 false true Reference 19181515 /api/reference/19181515 8. Igney, F.H., Krammer, P.H., Death and anti-death: Tumour resistance to apoptosis (2002) Nat. Rev. Cancer, 2, pp. 277-288 8 false true Reference 19181514 /api/reference/19181514 9. Zheng, X., Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer (2015) Nature, 527, pp. 525-530 9 false true Reference 19181512 /api/reference/19181512 10. Bandyopadhyay, S., FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis (2005) Oncogene, 24, pp. 5389-5395 10 false true Reference 19181511 /api/reference/19181511 11. Kusakabe, T., Nashimoto, A., Honma, K., Suzuki, T., Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach (2002) Histopathology, 40, pp. 71-79. , COI: 1:STN:280:DC%2BD387ntVSksg%3D%3D 11 false true Reference 19181510 /api/reference/19181510 12. Alo, P.L., Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients (1996) Cancer, 77, pp. 474-482 12 false true Reference 19181509 /api/reference/19181509 13. Furuta, E., Okuda, H., Kobayashi, A., Watabe, K., Metabolic genes in cancer: Their roles in tumor progression and clinical implications (1805) Biochem. Biophys. Acta., 141-152, p. 2010 13 false true Reference 19181508 /api/reference/19181508 14. Habermann, J.K., The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome (2009) Int. J. Cancer, 124, pp. 1552-1564 14 false true Reference 19181507 /api/reference/19181507 15. Carter, S.L., Eklund, A.C., Kohane, I.S., Harris, L.N., Szallasi, Z., A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers (2006) Nat. Genet., 38, pp. 1043-1048 15 false true Reference 19181506 /api/reference/19181506 16. Sarbia, M., Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities (1999) Int. J. Cancer, 84, pp. 86-91 16 false true Reference 19181505 /api/reference/19181505 17. Sebio, A., Kahn, M., Lenz, H.J., The potential of targeting Wnt/beta-catenin in colon cancer (2014) Expert Opin. Ther. Targets, 18, pp. 611-615 17 false true Reference 19181504 /api/reference/19181504 18. Harari, D., Yarden, Y., Molecular mechanisms underlying ErbB2/HER2 action in breast cancer (2000) Oncogene, 19, pp. 6102-6114 18 false true Reference 19181503 /api/reference/19181503 19. Miller, D.M., Thomas, S.D., Islam, A., Muench, D., Sedoris, K., c-Myc and cancer metabolism (2012) Clin. Cancer Res., 18, pp. 5546-5553 19 false true Reference 19181502 /api/reference/19181502 20. Zainuddin, A., Chua, K.H., Tan, J.K., Jaafar, F., Makpol, S., gamma-Tocotrienol prevents cell cycle arrest in aged human fibroblast cells through p16(INK4a) pathway (2017) J. Physiol. Biochem., 73, pp. 59-65 20 false true Reference 19181501 /api/reference/19181501 21. Zhao, X., Song, T., He, Z., Tang, L., Zhu, Y., A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma (2010) Med. Oncol., 27, pp. 985-991 21 false true Reference 19181500 /api/reference/19181500 22. Stein, G.H., Drullinger, L.F., Soulard, A., Dulic, V., Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts (1999) Mol. Cell Biol., 19, pp. 2109-2117 22 false true Reference 19181499 /api/reference/19181499 23. Nosho, K., Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype (2008) Histopathology, 53, pp. 588-598 23 false true Reference 19181498 /api/reference/19181498 24. Fu, Z.J., Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinoma in Chinese patients (2008) Clin. Exp. Metast., 25, pp. 887-892 24 false true Reference 19181497 /api/reference/19181497 25. Curtis, C., The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups (2012) Nature, 486, pp. 346-352 25 false true Reference 19181496 /api/reference/19181496 26. Sparano, J.A., Paik, S., Development of the 21-gene assay and its application in clinical practice and clinical trials (2008) J. Clin. Oncol., 26, pp. 721-728 26 false true Reference 19181495 /api/reference/19181495 27. Wang, Y., Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer (2005) Lancet, 365, pp. 671-679 27 false true Reference 19181494 /api/reference/19181494 28. Weigelt, B., Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer (2005) Can. Res., 65, pp. 9155-9158 28 false true Reference 19181493 /api/reference/19181493 29. Tamoxifen for early breast cancer: An overview of the randomised trials (1998) Lancet, 351, pp. 1451-1467 29 false true Reference 19181492 /api/reference/19181492 30. Fisher, B., Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer (1983) J. Clin. Oncol., 1, pp. 227-241 30 false true Reference 19181491 /api/reference/19181491 31. Romond, E.H., Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer (2005) N. Engl. J. Med., 353, pp. 1673-1684 31 false true Reference 19181490 /api/reference/19181490 32. Piccart-Gebhart, M.J., Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer (2005) N. Engl. J. Med., 353, pp. 1659-1672 32 false true Reference 19181489 /api/reference/19181489 33. Menyhart, O., Guidelines for the selection of functional assays to evaluate the hallmarks of cancer (1866) Biochem. Biophys. Acta., 300-319, p. 2016 33 false true Reference 19181488 /api/reference/19181488 34. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: The next generation (2011) Cell, 144, pp. 646-674 34 false true Reference 19181487 /api/reference/19181487 35. Hanahan, D., Weinberg, R.A., The hallmarks of cancer (2000) Cell, 100, pp. 57-70. , COI: 1:CAS:528:DC%2BD3cXks1CktA%3D%3D 35 false true Reference 19181486 /api/reference/19181486 36. Ding, L., Perspective on oncogenic processes at the end of the beginning of Cancer genomics (2018) Cell, 173, pp. 305-320 36 false true Reference 19181485 /api/reference/19181485 37. Cooper, L.A., PanCancer insights from the cancer genome atlas: The pathologist's perspective (2018) J. Pathol., 244, pp. 512-524 37 false true Reference 19181513 /api/reference/19181513 38. Espinoza, I., Miele, L., Notch inhibitors for cancer treatment (2013) Pharmacol. Ther., 139, pp. 95-110 38 false true /api/publication/31926259 Nagy Á. et al. Pancancer survival analysis of cancer hallmark genes. (2021) SCIENTIFIC REPORTS 2045-2322 11 1<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10047679"><a href="/gui2/?type=authors&mode=browse&sel=10047679" target="_blank">Nagy Á. (<span class="authorship-author-name">Nagy Ádám</span> <span class="authorAux-mtmt"> biológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Bioinformatika Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10024232"><a href="/gui2/?type=authors&mode=browse&sel=10024232" target="_blank">Munkácsy G. (<span class="authorship-author-name">Munkácsy Gyöngyi</span> <span class="authorAux-mtmt"> onkológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Bioinformatika Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10000109"><a href="/gui2/?type=authors&mode=browse&sel=10000109" target="_blank">Győrffy B. ✉ (<span class="authorship-author-name">Győrffy Balázs</span> <span class="authorAux-mtmt"> Onkológia</span>) </a> </span> <span class="author-affil"><span title="Természettudományi Kutatóközpont">TTK</span>/<span title="Enzimológiai Intézet">EI</span>/Onkológiai Biomarker Kutatócsoport (Lendület); <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Bioinformatika Tanszék</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;31926259" target="_blank">Pancancer survival analysis of cancer hallmark genes</a></div> <div> <span class="journal-title">SCIENTIFIC REPORTS</span> <span class="journal-issn">( <a target="_blank" href="https://portal.issn.org/resource/ISSN/2045-2322">2045-2322</a>)</span>: <span class="journal-volume">11</span> <span class="journal-issue">1</span> <span class="page"> Paper 6047. 10 p. </span> <span class="year">(2021)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.1038/s41598-021-84787-5" target="_blank" href="https://doi.org/10.1038/s41598-021-84787-5"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000630516600007" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000630516600007"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85102520763" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85102520763"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="33723286" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=33723286&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Multidisciplinary&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Szociológiai Tudományos Bizottság IXGJO SZTB [1901-]&nbsp;&nbsp;&nbsp;A nemzetközi</div> <div class="journal-subject">Regionális Tudományok Bizottsága IXGJO RTB [1901-]&nbsp;&nbsp;&nbsp;B nemzetközi</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 795</span> | Független: 784 | Függő: 11 | Nem jelölt: 0 | WoS jelölt: 769 | Scopus jelölt:&nbsp;729 | WoS/Scopus jelölt:&nbsp;795 | DOI jelölt:&nbsp;781 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;31926259&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 3 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 31926259</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">Scopus</span> </div> <div class="funder"> Magyar-koreai kutatás-fejlesztési együttműködési pályázat(2018-2.1.17-TÉT-KR-00001) Támogató: NKFIH, (2018-1.3.1-VKE-2018-00032), Thematic Excellence Program (Semmelweis University)(2020-4.1.1.-TKP2020) Támogató: Innovációs és Technológiai Minisztérium, (ÚNKP-19-3-IV-SE-5) Támogató: Innovációs és Technológiai Minisztérium </div> <div class="lastModified">Utolsó módosítás: 2024.12.06. 18:57 Milánkovics Róbert (PTE ÁOK admin 4) </div> </div></div>